Creative Biolabs-Immuno-oncology

Anti-DLX1 (clone 3C7J) SynExpress pB-mKa-cJ-K Modified CD8+ T cells (CAT#: ITS-1224-CR2148)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DLX1 (clone 3C7J). We employs the Lentivirus (pBAD-mKate-c-Jun-KpnI) vector components and the SynExpress system of the lncRNA Base Editing/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
DLX1
Clone
3C7J
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mKate
Promoter
pBAD
Effector Gene
c-Jun
Insertion Sites
KpnI
Gene Modification
Base Editing
Modification Domain
lncRNA
Carrier Type
Lentivirus
Transformation Accuracy
0.98
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.